The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 814
Tharayil, S. P., & Shukla, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136233 · Cited by 29
Daghestani, M. H., Daghestani, M. H., Warsy, A. S., El-Ansary, A. K., Omair, M. A., Omair, M. A., Hassen, L. M., Al-Humaidhi, E. M. H., Alqahtani, B., & Harrath, A. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665446 · Cited by 23
Role of genetic, environmental, and hormonal factors in the progression of PCOS: A review
Kumar, R., Minerva, S., Shah, R., Bhat, A., Verma, S., Chander, G., Bhat, G. R., Thapa, N., Bhat, A., Wakhloo, A. K., et al. (2022) · Journal of Reproductive Healthcare and Medicine · doi:10.25259/jrhm_16_2021 · Cited by 24
Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
Paczkowska, K., Rachoń, D., Berg, A., Rybka, J., Kapczyńska, K., Bolanowski, M., & Daroszewski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11010108 · Cited by 25
Hassan, N. E. S., Orabi, H. E., Eid, Y. M., & Mohammed, N. R. (2012) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2012.04.005 · Cited by 24
Long Menstrual Cycle Is Associated with Type 2 Diabetes Mellitus in Korean Women
Shim, U., Oh, J.-Y., Lee, H. J., Hong, Y. S., & Sung, Y. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.384 · Cited by 25
Insulin resistance and the polycystic ovary syndrome: recent advances
Nestler, J. E. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200012000-00009 · Cited by 24
Self-citationPolycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management
Kostopoulou, E., Anagnostis, P. G., Bosdou, J. Κ., Spiliotis, B. E., & Goulis, D. G. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00388-9 · Cited by 24
Lovejoy, J. C., Smith, S. R., Bray, G. A., Veldhuis, J. D., Rood, J. C., & Tulley, R. T. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90142-6 · Cited by 24
A contemporary view on global fertility, infertility, and assisted reproductive techniques
Barrera, N., Omolaoye, T. S., & du Plessis, S. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818309-0.00009-5 · Cited by 25
Maffazioli, G. D. N., Lopes, C. P., Heinrich‐Oliveira, V., Løbo, R. A., Hayashida, S. A. Y., Soares, J. M., Maciel, G. A. R., & Baracat, E. C. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13374 · Cited by 23
Adipositas und chronische Inflammation bei phlebologischen und lymphologischen Erkrankungen
Faerber, G. (2018) · Phlebologie · doi:10.12687/phleb2413-2-2018 · Cited by 24
Naseri, L., Khazaei, M. R., & Khazaei, M. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13635 · Cited by 22
Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes
Villaseca, P., Hormaza, P., Cárdenas, I., Oestreicher, E. M., & Arteaga, E. (2004) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180400007751 · Cited by 23
Tiitinen, A. E., Simberg, N., Stenman, U., & Ylikorkala, O. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045961 · Cited by 23
Rezvanian, H., Adibi, N., Siavash, M., Kachuei, A., Shojaee‐Moradie, F., & Asilian, A. (2008) · Dermatology · doi:10.1159/000187718 · Cited by 23
The relation between clinical manifestations of polycystic ovary syndrome and β‐cell function
Weber, R. F. A., Pache, T. D., Jacobs, M. L., Doctor, R., Loriaux, D. L., Fauser, B. C. J. M., & Birkenhäger, J. C. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01009.x · Cited by 23
Mlinar, B., Pfeifer, M., Bokal, E. V., Jensterle, M., & Marc, J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0387 · Cited by 23
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22
Kawai, M., Kakugawa, Y., Nishino, Y., Hamanaka, Y., Ohuchi, N., & Minami, Y. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0181-5 · Cited by 22
Hong, S., Sung, Y., Hong, Y. S., Jeong, K., Chung, H., & Lee, H. (2017) · Clinical Endocrinology · doi:10.1111/cen.13380 · Cited by 22
Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome
Maliqueo, M. A., Bacallao, K., Quezada, S., Clementi, M. A., Gabler, F., Johnson, M. C., & Vega, M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.06.038 · Cited by 22
Franchi, M., Asciutto, R., Nicotra, F., Merlino, L. G., Vecchia, C. L., Corrao, G., & Bosetti, C. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000235 · Cited by 22
Genetic basis of polycystic ovary syndrome
Barber, T., & Franks, S. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.32 · Cited by 22
Geisthövel, F., Frorath, B., & Brabant, G. E. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019118 · Cited by 22
Polycystic Ovary Syndrome Hyperandrogenism, and Insulin Resistance
Zacur, H. A. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70183-2 · Cited by 21
Ovulation induction techniques in women with polycystic ovary syndrome
Vyrides, A., Mahdi, E. E., & Giannakou, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.982230 · Cited by 27
Papaetis, G. S. (2021) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2021.105314 · Cited by 24
Wasserman, P., Segal‐Maurer, S., & Rubin, D. S. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00634.x · Cited by 21
Clinical implications of menstrual cycle length in oligomenorrhoeic young women
Oh, J. Y., Sung, Y., & Lee, H. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12243 · Cited by 21
Oride, A., Kanasaki, H., Purwana, I. N., & Miyazaki, K. (2010) · Pituitary · doi:10.1007/s11102-010-0223-x · Cited by 24
Çelik, Ö., Şahin, İ., Çelik, N., Hasçalık, Ş., Keskin, L., Özcan, H., Uçkan, A., & Kosar, F. (2007) · Human Reproduction · doi:10.1093/humrep/dem286 · Cited by 21
The polycystic ovary syndrome: the first 150 years of study
Adashi, E. Y., Cibula, D., Peterson, M., & Azziz, R. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.12.002 · Cited by 27
Long-term Alcohol Consumption and Risk of Endometrial Cancer Incidence: A Prospective Cohort Study
Friberg, E., & Wolk, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0993 · Cited by 20
Connolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 19
Puberty in the Female and Its Disorders
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00016-6 · Cited by 23
PERRY, A. C., Wang, X., Goldberg, R. B., Ross, R., & Jackson, L. (2013) · Obesity · doi:10.1002/oby.20204 · Cited by 23
Zweig, S. B., Tolentino, M. C., & Poretsky, L. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_38 · Cited by 19
Mlinar, B., Marc, J., Jensterle, M., Bokal, E. V., Jerin, A., & Pfeifer, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.002 · Cited by 20
Androgens and Therapeutic Aspects of Antiandrogens in Women
Diamanti‐Kandarakis, E., Tolis, G., & Dulęba, A. J. (1995) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(95)00002-v · Cited by 19
Panidis, D., Μacut, D., Farmakiotis, D., Rousso, D., Kourtis, A., Katsikis, I., Spanos, N., Petakov, M. S., Bjekić, J., & Damjanovic, S. S. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.12.016 · Cited by 20
Parker, J., Briden, L., & Gersh, F. L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124021 · Cited by 29
Xu, N., Geller, D. H., Jones, M. R., Funari, V. A., Azziz, R., & Goodarzi, M. O. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.06.002 · Cited by 19
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 19
Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?
Guarano, A., Capozzi, A., Cristodoro, M., Simone, N. D., & Lello, S. (2023) · Nutrients · doi:10.3390/nu15143209 · Cited by 26
Current treatment for polycystic ovary syndrome: focus on adolescence
Street, M. E., Cirillo, F., Catellani, C., Dauriz, M., Lazzeroni, P., Sartori, C., & Moghetti, P. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05861-2 · Cited by 19
Patlolla, S., Vaikkakara, S., Sachan, A., Venkatanarasu, A., Bachimanchi, B., Bitla, A. R. R., Settipalli, S., Pathiputturu, S., Sugali, R. N., & Chiri, S. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393062 · Cited by 19
Perelman, D., Coghlan, N., Lamendola, C., Carter, S., Abbasi, F., & McLaughlin, T. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1259407 · Cited by 18
Metformin in the Treatment of Polycystic Ovary Syndrome
Ab, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785294609 · Cited by 18
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 18
Jethaliya, H., Gajjar, N., Patel, V., Deshpande, S., & Patel, R. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00933-y · Cited by 17
Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
Ganie, M. A., Chakraborty, S., Sehgal, A., Sreejith, M., Kandasamy, D., Jana, M., & Rashid, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0733-7768 · Cited by 17
Barber, T. M., Bennett, A. J., Gloyn, A. L., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Taponen, S., Weedon, M. N., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201802 · Cited by 17
Association of polycystic ovary syndrome with cardiovascular risk factors
Akram, T., Hasan, S., Imran, M., Karim, A., & Arslan, M. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903159565 · Cited by 19
Antić, I. B., Ilic, D. S., Bjekić-Macut, J., Bogavac, T., Milutinović, D. V., Kastratović-Kotlica, B., Milic, N. M., Stanojlović, O. P., Andric, Z. G., & Μacut, D. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0775 · Cited by 17
The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
Pateguana, N. B., & Janes, A. N. (2019) · Journal of Metabolic Health · doi:10.4102/jir.v4i1.50 · Cited by 17
Lystedt, E., Westergren, H., Brynhildsen, J., Lindh‐Åstrand, L., Gustavsson, J., Nyström, F. H., Hammar, M. L., & Strålfors, P. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02027 · Cited by 17
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Acute Female Hypogonadism Alters Adipose Tissue Fatty Acid Storage Factors and Chylomicronemia
Santosa, S., Bonnes, S. L., & Jensen, M. D. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4065 · Cited by 16
The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome
Psilopatis, I., Vrettou, K., Nousiopoulou, E., Palamaris, K., & Theocharis, S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082912 · Cited by 16
Genetics of Common Endocrine Disease: The Present and the Future
Goodarzi, M. O. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3640 · Cited by 17
Glintborg, D., Altinok, M. L., Petersen, K. R., & Ravn, P. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-204797 · Cited by 16
Evaluation of insulin sensitivity status in polycystic ovarian syndrome
Wilma Delphine Silvia, C. R., Kavya, N., & Sweta, K. (2011) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(11)60017-0 · Cited by 16
To, W. W. K., & Wong, M. W. N. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.12.073 · Cited by 16
The pathogenetic enigma of polycystic ovary syndrome
Speca, S., Napolitano, C., & Tagliaferri, G. (2007) · Journal of Ultrasound · doi:10.1016/j.jus.2007.09.006 · Cited by 16
Hacıhanefioğlu, B., Aybey, B., Özön, Y. H., Berkil, H., & Karşıdağ, K. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743006 · Cited by 16
Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism
Schüring, A. N., Lutz, F., Tüttelmann, F., Gromoll, J., Kiesel, L., & Götte, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0529-1 · Cited by 16
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats
Patel, R., & Shah, G. B. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.001 · Cited by 16
Johnsen, S., Dolan, S. E., Fitch, K. V., Killilea, K. M., Shifren, J. L., & Grinspoon, S. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1083 · Cited by 16
Small doses of triiodothyronine can change some risk factors associated with abdominal obesity
Krotkiewski, M., Holm, G., & Shono, N. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800493 · Cited by 16
Dahan, M. H., & Goldstein, J. S. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.108 · Cited by 16
Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors
Toscano, V. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03350293 · Cited by 16
Adolescent androgen abnormalities
Stafford, D. E. J., & Gordon, C. M. (2002) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200210000-00002 · Cited by 16
Parveen, S., Khan, S., Ahsan, H., Manger, P. T., Gupta, B., & Alam, R. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200174 · Cited by 17
Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
Giannouli, A., Stefanaki, C., Kouskoutis, C., Konidari, M., Mani, I., Konidari, K., Markantonis, S. L., Mantzou, A., Dourakis, S. P., Deligeoroglou, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175744 · Cited by 15
Improving an Ovulation Rate in Women with Polycystic Ovary Syndrome by Using Silymarin
Taher, M. A., A.Atia, Y., & K.Amin, M. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol19iss2pp11-18 · Cited by 15
Diané, A., Kupreeva, M., Borthwick, F., Proctor, S. D., Pierce, W. D., & Vine, D. F. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0711 · Cited by 14
Liao, H., Chen, G., Wu, M., Liao, W., Tsai, I., & Kuo, C. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.11.073 · Cited by 16
Recent advances in the treatment of polycystic ovary syndrome
Yıldız, B. O. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1295 · Cited by 16
Nezi, M., CHRISTOPOULOS, P. F., Paltoglou, G., Gryparis, A., Bakoulas, V., Deligeoroglou, E., Creatsas, G. C., & Mastorakos, G. P. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0312 · Cited by 15
Reimbursement of metformin for polycystic ovary syndrome
Milewicz, A. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0025 · Cited by 18
Sternfeld, B., Liu, K., Quesenberry, C. P., Wang, H., Jiang, S.-F., Daviglus, M. L., Fornage, M., Lewis, C. E., Mahan, J. D., Schreiner, P. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2203 · Cited by 15
Identifying population-based approaches to lower breast cancer risk
Bernstein, L. (2008) · Oncogene · doi:10.1038/onc.2009.348 · Cited by 15
Strowitzki, T., & von Wolff, M. (2005) · Gynecological Surgery · doi:10.1007/s10397-005-0099-3 · Cited by 15
Polycystic Ovary Syndrome and Obesity
Barber, T. M., Dimitriadis, G. K., & Franks, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_15 · Cited by 15
The pathogenesis of osteoporosis in older women and men: a review
Enriori, P. J., & Enriori, C. L. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00144-9 · Cited by 16
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 16
Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women
McBreairty, L. E., Zello, G. A., Gordon, J. J., Serrao, S. B., Pierson, R. A., Chizen, D. R., & Chilibeck, P. D. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.10.007 · Cited by 14
Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management.
Nicolaides, N. C., Matheou, A., Vlachou, F., Neocleous, V., & Skordis, N. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10162 · Cited by 14
Improved Responsiveness of PCOS Patients to Clomiphene After CYP17a Inhibitor
Hassan, H. A., El-Gezeiry, D., Nafaa, T. M., & Baghdady, I. (2001) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1013165006406 · Cited by 13
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome
Ohgi, S., Nakagawa, K., Kojima, R., Ito, M., Horikawa, T., & Saito, H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.045 · Cited by 14
High Bone Mass Associated with Berardinelli Lipodystrophy
Bandeira, F. A. F., Miranda, C. R., Waechter, C., & Bandeira, E. (2007) · Endocrine Practice · doi:10.4158/ep.13.7.764 · Cited by 14
da Rocha, T. J. C. M., Crespo, R. P., Yance, V. D. R. V., Hayashida, S. A. Y., Baracat, E. C., Carvalho, F. M., Domenice, S., Mendonca, B. B., & Gomes, L. G. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00405 · Cited by 14
Johnston-MacAnanny, E. B., & Berga, S. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-52210-4_7 · Cited by 14
Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess
Silva, M. S. B., & Campbell, R. E. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210025 · Cited by 22
Birkeland, K. I., Hanssen, K. F., Torjesen, P. A., & Vaaler, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432768 · Cited by 161
Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01229-0 · Cited by 15
Yaghootkar, H., & Frayling, T. M. (2013) · Genome biology · doi:10.1186/gb-2013-14-3-203 · Cited by 14
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review